301201 诚达药业
已收盘 07-22 15:00:00
资讯
新帖
简况
7月20日诚达药业跌7.66%，富国睿泽回报混合基金重仓该股
证券之星 · 07-20 16:52
7月20日诚达药业跌7.66%，富国睿泽回报混合基金重仓该股
【机构调研记录】华宝基金调研诚达药业、金帝股份
证券之星 · 07-20 08:01
【机构调研记录】华宝基金调研诚达药业、金帝股份
股市必读：诚达药业（301201）7月17日披露最新机构调研信息
证券之星 · 07-20
股市必读：诚达药业（301201）7月17日披露最新机构调研信息
诚达药业：招商证券、华宝基金等多家机构于7月17日调研我司
证券之星 · 07-17
诚达药业：招商证券、华宝基金等多家机构于7月17日调研我司
7月17日诚达药业跌12.85%，富国睿泽回报混合基金重仓该股
证券之星 · 07-17
7月17日诚达药业跌12.85%，富国睿泽回报混合基金重仓该股
股市必读：诚达药业（301201）7月15日披露最新机构调研信息
证券之星 · 07-16
股市必读：诚达药业（301201）7月15日披露最新机构调研信息
诚达药业：有知名机构天倚道投资参与的多家机构于7月15日调研我司
证券之星 · 07-15
诚达药业：有知名机构天倚道投资参与的多家机构于7月15日调研我司
7月10日诚达药业涨6.28%，富国睿泽回报混合基金重仓该股
证券之星 · 07-10
7月10日诚达药业涨6.28%，富国睿泽回报混合基金重仓该股
诚达药业（301201）披露2025年度权益分派实施公告，7月9日股价下跌15.63%
证券之星 · 07-09
诚达药业（301201）披露2025年度权益分派实施公告，7月9日股价下跌15.63%
7月6日诚达药业涨12.83%，富国睿泽回报混合基金重仓该股
证券之星 · 07-06
7月6日诚达药业涨12.83%，富国睿泽回报混合基金重仓该股
诚达药业（301201）披露原持股5%以上股东减持计划实施结果公告，6月26日股价下跌3.52%
证券之星 · 06-26
诚达药业（301201）披露原持股5%以上股东减持计划实施结果公告，6月26日股价下跌3.52%
6月25日诚达药业发布公告，股东减持698.75万股
证券之星 · 06-25
6月25日诚达药业发布公告，股东减持698.75万股
股市必读：6月18日诚达药业现2笔折价18%的大宗交易 合计成交4024.45万元
证券之星 · 06-22
股市必读：6月18日诚达药业现2笔折价18%的大宗交易 合计成交4024.45万元
每周股票复盘：诚达药业（301201）现多笔折价18%大宗交易
证券之星 · 06-21
每周股票复盘：诚达药业（301201）现多笔折价18%大宗交易
股市必读：6月17日诚达药业现2笔折价18.13%的大宗交易 合计成交3190万元
证券之星 · 06-18
股市必读：6月17日诚达药业现2笔折价18.13%的大宗交易 合计成交3190万元
6月16日诚达药业涨5.75%，富国睿泽回报混合基金重仓该股
证券之星 · 06-16
6月16日诚达药业涨5.75%，富国睿泽回报混合基金重仓该股
股市必读：6月15日诚达药业现1笔折价18%的大宗交易 合计成交2097.48万元
证券之星 · 06-16
股市必读：6月15日诚达药业现1笔折价18%的大宗交易 合计成交2097.48万元
诚达药业：中邮证券投资者于6月10日调研我司
证券之星 · 06-10
诚达药业：中邮证券投资者于6月10日调研我司
诚达药业：兴业证券、招商证券等多家机构于6月9日调研我司
证券之星 · 06-09
诚达药业：兴业证券、招商证券等多家机构于6月9日调研我司
6月4日诚达药业发布公告，股东减持38.12万股
证券之星 · 06-04
6月4日诚达药业发布公告，股东减持38.12万股
加载更多
公司概况
公司名称：
诚达药业股份有限公司
所属行业：
医药制造业
上市日期：
2022-01-20
主营业务：
诚达药业股份有限公司的主营业务是为跨国制药企业及医药研发机构提供关键医药中间体、原料药CDMO研发生产服务，左旋肉碱系列产品、原料药的研发、生产和销售以及干细胞药物的研发。公司的主要产品是定制类产品和服务、自主销售类产品、贸易类、其他业务。
发行价格：
72.69
{"stockData":{"symbol":"301201","market":"SZ","secType":"STK","nameCN":"诚达药业","latestPrice":29.8,"timestamp":1784703825000,"preClose":30.32,"halted":0,"volume":7704530,"delay":0,"changeRate":-0.0172,"floatShares":109000000,"shares":155000000,"eps":-0.0228,"marketStatus":"已收盘","change":-0.52,"latestTime":"07-22 15:00:00","open":29.87,"high":31.35,"low":29.2,"amount":234000000,"amplitude":0.0709,"askPrice":29.83,"askSize":24,"bidPrice":29.8,"bidSize":15,"shortable":0,"etf":0,"ttmEps":-0.0228,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1784770200000},"marketStatusCode":5,"adr":0,"adjPreClose":30.32,"symbolType":"stock","openAndCloseTimeList":[[1784683800000,1784691000000],[1784696400000,1784703600000]],"highLimit":33.35,"lowLimit":27.29,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":154713824,"isCdr":false,"pbRate":2.23,"roa":"--","roe":"0.33%","epsLYR":-0.0787,"committee":-0.184211,"marketValue":4610000000,"turnoverRate":0.071,"status":1,"floatMarketCap":3235000000},"requestUrl":"/m/hq/s/301201","defaultTab":"news","newsList":[{"id":"2652993832","title":"7月20日诚达药业跌7.66%，富国睿泽回报混合基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2652993832","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2652993832?lang=zh_cn&edition=full","pubTime":"2026-07-20 16:52","pubTimestamp":1784537561,"startTime":"0","endTime":"0","summary":"证券之星消息，7月20日诚达药业跌7.66%创60日新低，收盘报30.74元，换手率9.62%，成交量10.44万手，成交额3.36亿元。重仓诚达药业的公募基金请见下表：该股最近90天内共有1家机构给出评级，增持评级1家。根据2026基金Q1季报公募基金重仓股数据，重仓该股的公募基金共5家，其中持有数量最多的公募基金为富国基金的富国睿泽回报混合。富国睿泽回报混合的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072000025262.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301201"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652833263","title":"【机构调研记录】华宝基金调研诚达药业、金帝股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2652833263","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2652833263?lang=zh_cn&edition=full","pubTime":"2026-07-20 08:01","pubTimestamp":1784505694,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息及7月17日披露的机构调研信息，华宝基金近期对2家上市公司进行了调研，相关名单如下：1）诚达药业 调研纪要：公司左旋肉碱系列产品价格稳定，出口全球30多个国家，已获中国NMPA、美国FDA、日本PMDA、欧洲CEP等多国认证，Self-GRAS认证已完成。2）金帝股份 调研纪要：2025年公司实现营业收入20.20亿元，同比增长49.07%，净利润1.47亿元，同比增长47.86%；2026年一季度营收5.27亿元，同比增长38.16%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072000001846.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0259","603270","301201"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652252143","title":"股市必读：诚达药业（301201）7月17日披露最新机构调研信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2652252143","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2652252143?lang=zh_cn&edition=full","pubTime":"2026-07-20 01:03","pubTimestamp":1784480590,"startTime":"0","endTime":"0","summary":"截至2026年7月17日收盘，诚达药业报收于33.29元，下跌12.85%，换手率11.13%，成交量12.09万手，成交额4.25亿元。当日关注点交易信息汇总：7月17日主力资金净流出2473.68万元，散户资金净流入3022.9万元。机构调研要点：公司反应设备总容积达141.55万升，具备多功能柔性化生产线及多次欧美客户质量审计通过记录。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072000000509.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301201"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652074794","title":"诚达药业：招商证券、华宝基金等多家机构于7月17日调研我司","url":"https://stock-news.laohu8.com/highlight/detail?id=2652074794","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2652074794?lang=zh_cn&edition=full","pubTime":"2026-07-17 19:01","pubTimestamp":1784286068,"startTime":"0","endTime":"0","summary":"证券之星消息，2026年7月17日诚达药业发布公告称招商证券方秋实、华宝基金魏扬帆于2026年7月17日调研我司。诚达药业2026年一季报显示，一季度公司主营收入1.28亿元，同比上升68.06%；归母净利润700.2万元，同比上升600.15%；扣非净利润309.86万元，同比上升152.93%；负债率9.78%，投资收益3.08万元，财务费用192.6万元，毛利率33.13%。该股最近90天内共有1家机构给出评级，增持评级1家。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071700037039.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0012","BK0183","BK1147","BK1564","600999","BK0028","BK0010","301201","BK0188","BK0276","06099","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652040955","title":"7月17日诚达药业跌12.85%，富国睿泽回报混合基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2652040955","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2652040955?lang=zh_cn&edition=full","pubTime":"2026-07-17 16:59","pubTimestamp":1784278790,"startTime":"0","endTime":"0","summary":"证券之星消息，7月17日诚达药业跌12.85%，收盘报33.29元，换手率11.13%，成交量12.09万手，成交额4.25亿元。根据2026基金Q1季报公募基金重仓股数据，重仓该股的公募基金共5家，其中持有数量最多的公募基金为富国基金的富国睿泽回报混合。富国睿泽回报混合目前规模为2.58亿元，最新净值1.8799，较上一交易日下跌1.83%，近一年上涨13.88%。富国睿泽回报混合的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071700030793.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301201","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651101460","title":"股市必读：诚达药业（301201）7月15日披露最新机构调研信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2651101460","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2651101460?lang=zh_cn&edition=full","pubTime":"2026-07-16 01:39","pubTimestamp":1784137149,"startTime":"0","endTime":"0","summary":"截至2026年7月15日收盘，诚达药业报收于37.94元，上涨2.26%，换手率13.04%，成交量14.15万手，成交额5.43亿元。当日关注点交易信息汇总：7月15日主力资金净流出998.87万元。机构调研要点7月15日特定对象调研公司目前开展的小分子GLP-1药物中间体有多个片段，将结合市场需求及客户需要拓展更多种类。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071600001817.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301201","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651465470","title":"诚达药业：有知名机构天倚道投资参与的多家机构于7月15日调研我司","url":"https://stock-news.laohu8.com/highlight/detail?id=2651465470","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2651465470?lang=zh_cn&edition=full","pubTime":"2026-07-15 21:02","pubTimestamp":1784120524,"startTime":"0","endTime":"0","summary":"证券之星消息，2026年7月15日诚达药业发布公告称天倚道投资郝俊辉于2026年7月15日调研我司。诚达药业2026年一季报显示，一季度公司主营收入1.28亿元，同比上升68.06%；归母净利润700.2万元，同比上升600.15%；扣非净利润309.86万元，同比上升152.93%；负债率9.78%，投资收益3.08万元，财务费用192.6万元，毛利率33.13%。该股最近90天内共有1家机构给出评级，增持评级1家。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071500043242.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301201"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650183060","title":"7月10日诚达药业涨6.28%，富国睿泽回报混合基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2650183060","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2650183060?lang=zh_cn&edition=full","pubTime":"2026-07-10 16:37","pubTimestamp":1783672632,"startTime":"0","endTime":"0","summary":"证券之星消息，7月10日诚达药业涨6.28%，收盘报36.88元，换手率16.76%，成交量18.19万手，成交额6.65亿元。重仓诚达药业的公募基金请见下表：该股最近90天内共有1家机构给出评级，增持评级1家。根据2026基金Q1季报公募基金重仓股数据，重仓该股的公募基金共5家，其中持有数量最多的公募基金为富国基金的富国睿泽回报混合。富国睿泽回报混合的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071000029318.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301201","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650940926","title":"诚达药业（301201）披露2025年度权益分派实施公告，7月9日股价下跌15.63%","url":"https://stock-news.laohu8.com/highlight/detail?id=2650940926","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2650940926?lang=zh_cn&edition=full","pubTime":"2026-07-09 17:17","pubTimestamp":1783588677,"startTime":"0","endTime":"0","summary":"截至2026年7月9日收盘，诚达药业报收于34.7元，较前一交易日下跌15.63%，最新总市值为53.69亿元。该股当日开盘39.4元，最高40.81元，最低33.34元，成交额达9.01亿元，换手率为22.53%。公司于近日披露《2025年度权益分派实施公告》。本次权益分派实施后，相关股东减持价及除权除息参考价将作相应调整。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070900030239.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301201"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649642025","title":"7月6日诚达药业涨12.83%，富国睿泽回报混合基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2649642025","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2649642025?lang=zh_cn&edition=full","pubTime":"2026-07-06 16:45","pubTimestamp":1783327548,"startTime":"0","endTime":"0","summary":"证券之星消息，7月6日诚达药业涨12.83%，收盘报42.65元，换手率20.03%，成交量21.74万手，成交额8.94亿元。重仓诚达药业的公募基金请见下表：该股最近90天内共有1家机构给出评级，增持评级1家。根据2026基金Q1季报公募基金重仓股数据，重仓该股的公募基金共5家，其中持有数量最多的公募基金为富国基金的富国睿泽回报混合。富国睿泽回报混合的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070600022448.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301201"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646355402","title":"诚达药业（301201）披露原持股5%以上股东减持计划实施结果公告，6月26日股价下跌3.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2646355402","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2646355402?lang=zh_cn&edition=full","pubTime":"2026-06-26 17:56","pubTimestamp":1782467802,"startTime":"0","endTime":"0","summary":"截至2026年6月26日收盘，诚达药业报收于36.17元，较前一交易日下跌3.52%，最新总市值为55.96亿元。诚达药业股份有限公司于2026年6月25日发布公告，原持股5%以上股东深圳前海晟泰投资企业在2026年6月3日至6月24日期间，通过集中竞价和大宗交易方式累计减持公司股份7,368,706股，占公司总股本比例4.76%。其中集中竞价减持381,206股，大宗交易减持6,987,500股。本次减持后，前海晟泰持有股份降至748,091股，占总股本比例0.48%，不再为持股5%以上股东。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062600033519.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301201","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646706538","title":"6月25日诚达药业发布公告，股东减持698.75万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2646706538","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2646706538?lang=zh_cn&edition=full","pubTime":"2026-06-25 20:01","pubTimestamp":1782388902,"startTime":"0","endTime":"0","summary":"证券之星消息，6月25日诚达药业发布公告《诚达药业:关于原持股5%以上股东减持计划实施结果的公告》，其股东深圳前海晟泰投资企业(有限合伙)于2026年6月11日至2026年6月22日间合计减持698.75万股，占公司目前总股本的4.5164%，变动期间该股股价上涨5.9%，截止6月22日收盘报35.7元。股东增减持详情见下表：根据诚达药业2026年一季报公布的十大股东详情如下：本文数据来源于诚达药业公告，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062500039689.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301201","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645016355","title":"股市必读：6月18日诚达药业现2笔折价18%的大宗交易 合计成交4024.45万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2645016355","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645016355?lang=zh_cn&edition=full","pubTime":"2026-06-22 04:10","pubTimestamp":1782072621,"startTime":"0","endTime":"0","summary":"截至2026年6月18日收盘，诚达药业报收于35.72元，上涨0.85%，换手率3.81%，成交量4.13万手，成交额1.47亿元。交易信息汇总资金流向6月18日主力资金净流出376.8万元，占总成交额0.0%；游资资金净流出94.34万元，占总成交额0.0%；散户资金净流入471.15万元，占总成交额0.0%。大宗交易6月18日诚达药业发生2笔折价18%的大宗交易，合计成交4024.45万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062200001436.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301201","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645096618","title":"每周股票复盘：诚达药业（301201）现多笔折价18%大宗交易","url":"https://stock-news.laohu8.com/highlight/detail?id=2645096618","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645096618?lang=zh_cn&edition=full","pubTime":"2026-06-21 03:00","pubTimestamp":1781982032,"startTime":"0","endTime":"0","summary":"截至2026年6月18日收盘，诚达药业报收于35.72元，较上周的33.18元上涨7.66%。本周，诚达药业6月16日盘中最高价报36.31元。诚达药业当前最新总市值55.26亿元，在医疗服务板块市值排名29/51，在两市A股市值排名3049/5206。本周关注点交易信息汇总：6月15日至18日，诚达药业连续出现多笔折价约18%的大宗交易，合计成交金额超1.19亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062100000922.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301201","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644255757","title":"股市必读：6月17日诚达药业现2笔折价18.13%的大宗交易 合计成交3190万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2644255757","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2644255757?lang=zh_cn&edition=full","pubTime":"2026-06-18 02:27","pubTimestamp":1781720831,"startTime":"0","endTime":"0","summary":"截至2026年6月17日收盘，诚达药业报收于35.42元，上涨0.83%，换手率4.24%，成交量4.6万手，成交额1.63亿元。当日关注点交易信息汇总：6月17日主力资金净流入1041.39万元，游资资金净流入152.28万元，散户资金净流出1193.67万元； 交易信息汇总：当日发生2笔折价18.13%的大宗交易，合计成交3190万元。大宗交易6月17日诚达药业发生2笔大宗交易，折价率18.13%，合计成交金额3190万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061800001767.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301201","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643737090","title":"6月16日诚达药业涨5.75%，富国睿泽回报混合基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2643737090","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2643737090?lang=zh_cn&edition=full","pubTime":"2026-06-16 16:43","pubTimestamp":1781599416,"startTime":"0","endTime":"0","summary":"证券之星消息，6月16日诚达药业涨5.75%，收盘报35.13元，换手率5.88%，成交量6.38万手，成交额2.21亿元。重仓诚达药业的公募基金请见下表：该股最近90天内共有1家机构给出评级，增持评级1家。根据2026基金Q1季报公募基金重仓股数据，重仓该股的公募基金共5家，其中持有数量最多的公募基金为富国基金的富国睿泽回报混合。富国睿泽回报混合的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061600029140.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301201"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643214200","title":"股市必读：6月15日诚达药业现1笔折价18%的大宗交易 合计成交2097.48万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2643214200","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2643214200?lang=zh_cn&edition=full","pubTime":"2026-06-16 01:55","pubTimestamp":1781546112,"startTime":"0","endTime":"0","summary":"截至2026年6月15日收盘，诚达药业报收于33.22元，上涨0.12%，换手率3.4%，成交量3.69万手，成交额1.22亿元。当日关注点交易信息汇总：6月15日诚达药业主力资金净流出810.08万元，游资与散户资金分别净流入222.07万元、588.02万元。大宗交易6月15日诚达药业现1笔折价18%的大宗交易，合计成交2097.48万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061600001376.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301201","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642425630","title":"诚达药业：中邮证券投资者于6月10日调研我司","url":"https://stock-news.laohu8.com/highlight/detail?id=2642425630","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642425630?lang=zh_cn&edition=full","pubTime":"2026-06-10 20:02","pubTimestamp":1781092939,"startTime":"0","endTime":"0","summary":"证券之星消息，2026年6月10日诚达药业发布公告称中邮证券分析师 盛丽华 陈灿 辛家齐于2026年6月10日调研我司。诚达药业2026年一季报显示，一季度公司主营收入1.28亿元，同比上升68.06%；归母净利润700.2万元，同比上升600.15%；扣非净利润309.86万元，同比上升152.93%；负债率9.78%，投资收益3.08万元，财务费用192.6万元，毛利率33.13%。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061000038073.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["161027","301201","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642641724","title":"诚达药业：兴业证券、招商证券等多家机构于6月9日调研我司","url":"https://stock-news.laohu8.com/highlight/detail?id=2642641724","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642641724?lang=zh_cn&edition=full","pubTime":"2026-06-09 19:01","pubTimestamp":1781002915,"startTime":"0","endTime":"0","summary":"证券之星消息，2026年6月9日诚达药业发布公告称兴业证券分析师 乔波耀、招商证券分析师 侯彪、中泰证券分析师 杨涛于2026年6月9日调研我司。公司将积极推动干细胞项目国内IND申报及临床研究，加快产品上市进程。诚达药业2026年一季报显示，一季度公司主营收入1.28亿元，同比上升68.06%；归母净利润700.2万元，同比上升600.15%；扣非净利润309.86万元，同比上升152.93%；负债率9.78%，投资收益3.08万元，财务费用192.6万元，毛利率33.13%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060900032719.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["601377","BK0010","BK0028","BK0188","301201","BK1147","06099","BK0276","BK1564","600999","BK0183","BK0239","BK0012"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640815483","title":"6月4日诚达药业发布公告，股东减持38.12万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2640815483","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640815483?lang=zh_cn&edition=full","pubTime":"2026-06-04 19:01","pubTimestamp":1780570866,"startTime":"0","endTime":"0","summary":"证券之星消息，6月4日诚达药业发布公告《诚达药业:诚达药业股份有限公司简式权益变动报告书》，其股东深圳前海晟泰投资企业(有限合伙)于2026年6月3日合计减持38.12万股，占公司目前总股本的0.2464%，变动期间该股股价上涨3.75%，截止6月3日收盘报34.86元。股东增减持详情见下表：根据诚达药业2026年一季报公布的十大股东详情如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060400035383.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301201","BK0239"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1784760024879,"stockEarnings":[{"period":"1week","weight":-0.2145},{"period":"1month","weight":-0.1608},{"period":"3month","weight":-0.2505},{"period":"6month","weight":-0.2725},{"period":"1year","weight":-0.0576},{"period":"ytd","weight":-0.2639}],"compareEarnings":[{"period":"1week","weight":-0.0224},{"period":"1month","weight":-0.0711},{"period":"3month","weight":-0.0553},{"period":"6month","weight":-0.0651},{"period":"1year","weight":0.0796},{"period":"ytd","weight":-0.0257}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"诚达药业股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"14295人(较上一季度增加10.28%)","perCapita":"7593股","listingDate":"2022-01-20","address":"浙江省嘉兴市嘉善县惠民街道黄河路36号","registeredCapital":"15471万元","survey":" 诚达药业股份有限公司的主营业务是为跨国制药企业及医药研发机构提供关键医药中间体、原料药CDMO研发生产服务，左旋肉碱系列产品、原料药的研发、生产和销售以及干细胞药物的研发。公司的主要产品是定制类产品和服务、自主销售类产品、贸易类、其他业务。","listedPrice":72.69},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"诚达药业(301201)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供诚达药业(301201)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"诚达药业,301201,诚达药业股票,诚达药业股票老虎,诚达药业股票老虎国际,诚达药业行情,诚达药业股票行情,诚达药业股价,诚达药业股市,诚达药业股票价格,诚达药业股票交易,诚达药业股票购买,诚达药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"诚达药业(301201)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供诚达药业(301201)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}